International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-5 doi: 10.5281/zenodo.8360734
Original Article
A Study of Congenital Abnormalities of Female Genital Tract: In A Tertiary Care Center
 ,
 ,
Published
Sept. 18, 2023
Abstract

Introduction: Developmental anomalies of female genital tract are not very common, incidence reported in the literature is0.2%–3.8% [1] Depending on the specific defect, a woman’s obstetric and gynaecologic health may be adversely affected.

Aims and Objectives: Through the present study we aim to evaluate the various clinical presentations of congenital anomalies of female genital tract, appropriate management used for the respective cases to improve both obstetric and gynaecological outcome.

Methods: A prospective observational study was conducted at the Maharajah‘s Institute of Medical sciences, Obstetrics and Gynaecology department for a period of 3 years. Among more than 3000 patients reporting in the outpatient department within the above mentioned time period, 13 cases of  female genital tract developmental defects were diagnosed through clinical history, physical examination, hormonal study, imaging-studies and  hysterolaparoscopy. The optimum mode of management for each case was individualised and assessed in terms of the final outcome and is being followed-up.

Results: Present study shows prevalence of mullerian anomalies is 0.4 % at our tertiary care center. Main presenting symptoms were primary amenorrhoea and infertility. Most of the patients belonged to the adolescent age group.

Conclusion: Female genital tract anomalies are a morphological diverse group of developmental disorders. The surgical approach for correction is specific to the type of malformation. Due to the frequent association between müllerian and urinary anomalies, the finding of any of the types should lead to the investigation of the other [2].

Recommended Articles
Loading Image...
Volume-4, Issue-5
Citations
2494 Views
286 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved